프로바이오틱스(Lactiplantibacillus plantarum KC3)·익모초추출복합물(CKDB-315)(제2025-1호)
프로바이오틱스(Lactiplantibacillus plantarum KC3)·익모초추출복합물(CKDB-315)(제2025-1호)
MFDS recognition no.
제2025-1호
Approval route
Individually approved (개별인정형) — only the approval holder may use this wording
Daily intake (as approved)
980.0–980.0 mg/일
Approved wording (Korean original)
(국문) 기관·기관지 상태(기침·가래 등) 개선에 도움을 줄 수 있음
(영문) May help to improve trachea·bronchi condition (cough·sputum etc)
Precautions (Korean original)
(1) 영·유아, 임산부 및 수유부는 섭취를 피할 것
(2) 특정 질환(알레르기 체질, 단장 증후군 등)이 있거나 의약품 복용 시 전문가와 상담할 것
(3) 이상사례 발생 시 섭취를 중단하고 전문가와 상담할 것
(4) 어린이가 함부로 섭취하지 않도록 일일섭취량 방법을 지도할 것
the FDA, EFSA or your national authorityRequirements differ by market. Confirm ingredient status and label wording with your own authority before importing.
Approvals described here were issued by the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea and are valid in South Korea only. They are not health claims in your jurisdiction and have not been evaluated by the FDA, EFSA, or any other authority. This page reports regulatory facts and does not recommend any product.